Search

A study from Amirkabir University of Technology in Tehran, Iran, focuses on the innovative use of nanogels in biomedical engineering, particularly in drug delivery, tissue engineering, and bioimaging. Nanogels, which combine hydrogel and nanoparticle properties, offer unique characteristics such as high water content and biocompatibility, making them versatile platforms for various biomedical applications. Despite promising preclinical results, challenges remain in translating nanogel technologies into clinical practice, with a need for further research to optimize their properties and applications for enhanced efficacy and safety in clinical settings. [Extracted from the article]

Researchers from Shahid Beheshti University in Tehran, Iran, have published a study on the advancements in nanotechnology-driven targeted drug delivery for lung cancer treatment. The study highlights the potential of nanocarriers, such as solid lipid nanoparticles and gold nanoparticles, to enhance therapeutic effectiveness and reduce systemic toxicity. By leveraging tumor-specific markers and stimuli-responsive release mechanisms, these innovative approaches aim to provide more personalized and effective treatment options for patients with lung cancer. The research emphasizes the transformative impact that nanotechnology could have on the therapeutic landscape for lung cancer, offering more efficient and targeted modalities for treatment. [Extracted from the article]

A recent study conducted at the Graduate University of Advanced Technology in Kerman, Iran, explored the use of biocompatible quince seed mucilage hydrogel as a material for drug delivery systems. The hydrogel showed promising results as a carrier for ceftriaxone antibiotic release, with an impressive encapsulation efficiency of 96.1%. The research concluded that the proposed hydrogel structure (III) has potential as an efficient carrier system for drug delivery applications. [Extracted from the article]

Researchers from Ferdowsi University of Mashhad in Iran have developed a novel nanoplatform for smart drug delivery in colorectal cancer therapy. The researchers modified mesoporous silica nanoparticles (MSNs) with a gatekeeper molecule, an inverted umbrella consisting of a deferiprone-copper complex, to achieve controlled release of the drug doxorubicin (DOX) within tumor cells. The nanoplatform, called Apt-PEG-DOX@GNP, demonstrated targeted toxicity towards colorectal tumors in in vivo experiments, resulting in minimal side effects. This research shows promising potential for targeted treatment of colorectal cancer and precise control over drug release. [Extracted from the article]

A recent study conducted at the University of Tehran in Iran has explored the use of smart materials for delivering anticancer drugs to tumors. The researchers developed a pH-responsive system using magnetite nanoparticles and bentonite loaded with doxorubicin, an anticancer drug. The structural and spectral properties of the nanohybrid were analyzed, and its drug-loading capacity and release were measured. The results showed that the magnetic bentonite nanohybrid has potential as a drug delivery system for targeting cancer cells. [Extracted from the article]

A recent study conducted by the Academic Center for Education Culture and Research (ACECR) in Tehran, Iran, explores the potential of nanobiomimetic structures as drug delivery systems. These structures, inspired by nature, have the ability to revolutionize disease treatment by enabling precise and targeted drug delivery. The study examines the physicochemical properties of nanobiomimetic structures, such as hydrophilicity, particle shape, surface charge, composition, and concentration, and discusses the use of specific ligands to enhance their specificity towards target cells. The research also explores innovative strategies to improve drug loading capacity, cellular uptake, and sustained release of drugs in target cells. The study concludes by highlighting the immense potential of nanobiomimetic drug carriers in transforming the field of drug delivery. [Extracted from the article]

A report from investigators at Sharif University of Technology in Tehran, Iran, discusses the use of tumor spheroid-on-chip models to study drug delivery systems. The researchers developed microfluidic devices that closely resemble in vivo conditions and studied drug transport using porous media theory. The results showed that the proposed models effectively mimic in vivo conditions, including drug delivery through blood vessels. This research provides a strategy for evaluating the reliability of in vitro models in replicating intratumoral drug delivery. The study was supported by the Iran National Science Foundation and has been peer-reviewed. [Extracted from the article]

A recent study conducted at Shiraz University of Medical Sciences in Iran has highlighted the urgent need for new diagnostic and therapeutic strategies for cardiovascular diseases (CVD). Despite advancements in treatment, CVD remains a leading cause of death worldwide. The study focuses on the potential use of magnetic nanoparticles (MNPs) and their hybrid biomaterials for enhancing the efficacy of CVD detection and treatment. MNPs offer new approaches for targeting CVD, reducing drug toxicity, and achieving positive outcomes in diagnosing blood vessel and heart diseases. The research provides a comprehensive overview of MNPs, their characteristics, synthesis methods, and their applications in cardiovascular diseases. [Extracted from the article]

A recent study conducted at Sharif University of Technology in Tehran, Iran, has focused on the development of nanogels as a drug delivery system for doxorubicin, an antineoplastic drug used in chemotherapy. The nanogels are designed to be light-sensitive and biocompatible, with a core-shell structure that allows for controlled drug release. The researchers found that the nanogels demonstrated sustainable drug release under light irradiation, leading to decreased viability of cancer cells and potential efficacy in cancerous tissues. This research provides valuable insights into the potential of nanotechnology in improving drug delivery systems and reducing the side effects of chemotherapy. [Extracted from the article]

A study conducted by researchers at Kermanshah University of Medical Sciences in Iran explores the use of hydrogel-based drug delivery systems for synergistic chemo/hyperthermia therapy of cancer. The study highlights the advantages of chemotherapy as a cancer treatment, such as its simplicity and efficacy. However, it also acknowledges the drawbacks, such as side effects and drug resistance. The researchers propose using natural and stimuli-responsive hydrogels to formulate anti-cancer drugs and reduce the side effects of conventional chemotherapy. The study concludes by focusing on recent progress in combined chemo/hyperthermia therapy using hydrogels as a synergistic cancer treatment strategy. [Extracted from the article]

A recent report from Tabriz University of Medical Sciences in Iran discusses the use of paclitaxel (PTX) in breast cancer therapy. PTX is a chemotherapeutic agent that inhibits cell division and has shown promise in treating various types of cancer, including breast cancer. The report highlights the potential of combining PTX with other compounds and drugs to enhance its antitumor properties. Additionally, the use of nanoparticles as a targeted drug delivery system is explored as a way to improve the efficacy of drugs while minimizing side effects. The research aims to reduce multidrug resistance and cancer recurrence in breast cancer therapy. [Extracted from the article]

Researchers at the Royan Institute for Biotechnology in Esfahan, Iran have developed a new method for drug delivery using bacterial cellulose (BC) and gelatin reinforced with carboxylic carbon nanotubes (cMWCNTs). The nanocomposite scaffold showed improved surface area, porosity, wettability, and biodegradation rate. The controlled release of a drug model, human serum albumin (HSA), was achieved with a zero-order kinetic mechanism, and the nanocomposite exhibited favorable cell behavior without cytotoxic effects. This research offers a promising avenue for sustained drug delivery and tissue regeneration. [Extracted from the article]

A recent report from K.N. Toosi University of Technology in Tehran, Iran discusses the use of an intratumoral implantable drug delivery system for targeted localized chemotherapy in breast cancer. The study focuses on simulating the performance of chemotherapy using different drugs loaded in a dual release implantable system. The results show that the elimination rate and diffusion mechanism play a crucial role in determining the effectiveness of the therapeutic agents. The study highlights the potential of this dual implantable system as an effective approach for chemotherapy, particularly in tumors with low microvascular density. These findings provide valuable insights for future research in the development of local drug delivery systems for breast cancer treatment. [Extracted from the article]

Researchers from K.N. Toosi University of Technology in Tehran, Iran have developed a computational model to improve the effectiveness of microwave ablation (MWA) therapy for cancer treatment. The model focuses on the delivery of thermosensitive liposomes (TSLs) that release drugs in response to heat. The study found that the combination of TSLs with MWA allows for more localized drug delivery with lower side effects, and the computational model predicted an increase in the destruction of cancer cells compared to MWA alone. The research highlights the potential of this computational framework for future advancements in cancer treatment. [Extracted from the article]

Researchers at Shiraz University of Medical Sciences in Iran have conducted a study on the structural and dynamical properties of cationic, anionic, and catanionic niosomes as multifunctional controlled drug delivery systems. Niosomes are nanocarriers for therapeutic compounds, and optimizing their structures with ionic surfactants can significantly enhance their functionality. The researchers aimed to design and evaluate catanionic niosomes as vehicles for anticancer agents. The study found that catanionic niosomes have the potential to be effective carriers for anticancer drugs. This research has been peer-reviewed and provides valuable insights into drug delivery systems. [Extracted from the article]

A study conducted by researchers from Islamic Azad University in Tehran, Iran, explores the synthesis of a temperature-responsive nanocarrier for the controlled delivery of paclitaxel and photo-thermal therapy. The nanocarrier, which was grafted onto a nanodiamond surface and conjugated with polyester dendrimer, demonstrated dose-dependent cytotoxicity towards MCF-7 cancer cells. The research findings suggest that this nanocarrier has the potential to improve the delivery of anti-tumor drugs to tumor cells in a more controllable condition. Financial support for this research came from Islamic Azad University. [Extracted from the article]

Researchers at the Chemistry and Chemical Engineering Research Center of Iran have designed a novel trifunctional nanocomposite for efficient drug delivery in cancer treatment. The nanocomposite, which has luminescent, magnetic, and pH-responsive properties, was loaded with methotrexate (MTX) and doxorubicin (DOX) for controlled release. In vitro studies showed that the nanocomposite had low cytotoxicity and high cell viability against breast cancer cells, and it demonstrated higher uptake and apoptotic effects compared to free drugs. The researchers concluded that the nanocomposite could be used as a non-toxic carrier for targeted therapy and controlled drug release in breast cancer treatment. [Extracted from the article]

Researchers at Kermanshah University of Medical Sciences in Iran have conducted a study on enhancing the efficacy of cisplatin, a platinum-based chemotherapeutic agent, in breast cancer treatment. They focused on developing a sericin-based nanocarrier (SNC) to effectively transport cisplatin into breast cancer cells. The study found that the SNCs demonstrated stability, exhibited pH-dependent drug release behavior, and showed efficient cellular uptake in breast cancer cells. The researchers concluded that protein-based nanocarriers hold promise for targeted drug delivery in cancer therapy. [Extracted from the article]

A recent study conducted by researchers at Rafsanjan University of Medical Sciences in Iran explores the use of nanomedicine for targeted drug delivery in breast cancer treatment. The researchers developed a modified Sba-15 mesoporous nanostructure to deliver the anticancer drug quercetin. The nanostructure was functionalized with a carrier and capping agent, and folic acid was used to target the drug delivery. The study found that the formulation made from quercetin was more toxic to breast cancer cells compared to healthy cells, likely due to the presence of folic acid. The research provides insights into the potential of nanotechnology in improving cancer therapies. [Extracted from the article]

A study conducted at Islamic Azad University in Ahvaz, Iran, has developed a new drug delivery system using graphene oxide (GO) and 5-fluorouracil (5-FU) for controlled drug release. The researchers synthesized a nanocarrier system by attaching 5-FU to GO through a stacking interaction. The system showed strong pH dependence and increased drug release at higher temperatures. The study suggests that this drug delivery technique has potential applications in biological and biomedical fields. The research was supported by the Research Council of Ahvaz Branch, Islamic Azad University. [Extracted from the article]

A recent report discusses research conducted at Islamic Azad University in Ilam, Iran, on the development of an intelligent device for controlled release of anti-cancer drugs. The device consists of magnetic nanoparticles that are functionalized to attach anti-cancer drugs, and a polymer that encapsulates the drug-loaded nanoparticles. The polymer exhibits a phase transition behavior at a specific temperature, and in vitro release assessments showed higher drug releases at temperatures exceeding this threshold and at slightly acidic pH levels. The researchers concluded that this nano-carrier shows promise as a targeted therapeutic delivery system for cancer treatment. [Extracted from the article]

A report from Shaheed Beheshti University of Medical Sciences in Tehran, Iran discusses the potential of implantable drug delivery systems (IDDS) for cancer treatment. Conventional chemotherapy regimens have limitations such as high-dose requirements and adverse effects, and IDDS aim to address these challenges by delivering anti-cancer drugs directly to the intended sites of action while minimizing side effects. The report summarizes different types of IDDS, including nanofibers, films, hydrogels, and osmotic pumps, and highlights their advantages and release behavior. The effectiveness of IDDS in treating various types of cancer, including breast cancer, glioblastoma, and liver cancer, is also discussed. The report concludes by emphasizing the need for further clinical trials to ensure the efficiency of IDDS in cancer therapy. [Extracted from the article]

A research study conducted at Sharif University of Technology in Tehran, Iran, has developed an injectable and biodegradable drug delivery system for treating anti-bone infection. The system utilizes nanocomposites of hydroxyapatite nanoparticles (HAP) and double-network hydrogels of sodium alginate (SA)/polyvinyl alcohol (PVA) in the form of microspheres embedded in injectable agar gel. The drug release rate was found to be influenced by the composition of the delivery system components, with an increase in PVA content leading to a slower release rate. The drug-loaded composite hydrogels demonstrated antibacterial effectiveness against E. coli bacteria. [Extracted from the article]

A recent study conducted at the University of Mazandaran in Babolsar, Iran, explored the use of nanodiamonds in enhancing the delivery of anti-cancer drugs, specifically doxorubicin and melphalan. The researchers used density functional theory calculations to investigate the interaction and electronic properties of these drugs on pristine and Cr-doped nanodiamonds. The results showed that doping the nanodiamonds with chromium (Cr) enhanced the drug loading capacity, making them potential carriers for doxorubicin and melphalan. The study suggests that Cr-doped nanodiamonds could be used to improve drug delivery efficacy. [Extracted from the article]

A recent study conducted by researchers at Mazandaran University of Medical Sciences in Sari, Iran, explores the development of nanosize carrier systems for Amphotericin-B (Am-B) in the treatment of Leishmaniasis and fungal infections. The researchers highlight the need for safe and effective drug delivery systems for Am-B due to issues such as organ cytotoxicity, low bioavailability, high costs, and technical problems associated with current formulations. They discuss the potential of nano-based technology and nanomaterials in designing novel drug delivery systems, including solid lipid nanostructured materials, liposomes, polymer and protein-based nanostructured materials, and more. These advancements in Am-B formulations show promise in the treatment of human systemic infections and are currently undergoing clinical tests. [Extracted from the article]

Researchers at the University of Tabriz in Iran have developed a new drug delivery system using magnetic hydroxyapatite-MIL-100 metal-organic frameworks (MOFs) and graphene quantum dots (GQDs). The nanocomposites were found to have a pH-responsive controlled release of the drug doxorubicin (DOX) and demonstrated no significant cytotoxicity. The researchers concluded that these drug delivery systems have the potential to be used safely in targeted cancer therapy. The study was published in the journal Diamond and Related Materials. [Extracted from the article]

A recent study conducted at the University of Tabriz in Iran has focused on the synthesis and characterization of magnetic bio-nanocomposite hydrogel beads for potential pH-sensitive drug delivery in tissue engineering. The researchers successfully synthesized the bio-nanocomposites and found that they exhibited pH-sensitive swelling behavior. The beads also demonstrated a high loading capacity for an anticancer drug and a pH-sensitive drug release profile. The study suggests that these magnetic bio-nanocomposite hydrogel beads have potential for use in implantable pH-sensitive drug delivery systems for the treatment of cancerous tissue. [Extracted from the article]

Researchers at the University of Tabriz in Iran have developed a biocompatible pH-sensitive nanocarrier for targeted anticancer drug delivery. The nanocarrier, called LDH@HAp-DOX@Fe3O4-PEG, was found to have a controlled release profile and higher toxicity against MCF-7 breast cancer cells compared to free DOX. The study concluded that the nanocomposite shows promise as a candidate for targeted drug delivery, potentially minimizing side effects. The research was supported by the University of Tabriz and has been peer-reviewed. [Extracted from the article]

A study conducted by researchers at Mazandaran University of Medical Sciences in Iran explores the use of liposomes in the treatment of leishmaniasis, a common parasitic disease in tropical and subtropical regions. Liposomes are bilayered structures made of phospholipids and cholesterol that can deliver hydrophobic, hydrophilic, or amphiphilic compounds. By utilizing the different structural features of liposomes, such as particle size and surface charge, and attaching ligands to their surface, targeted drug delivery to the leishmaniasis parasite can be achieved. The study highlights the use of sugar-coated liposomes, cationic liposomes, arsenoliposomes, and peptide-targeted liposomes in delivering traditional anti-leishmaniasis drugs, and emphasizes the ongoing research in this field. [Extracted from the article]

A recent study conducted at Shiraz University of Medical Sciences in Iran compared the potential of chitosan-coated magnetite nanospheres (MNSs) and magnetite nanorods (MNRs) as carriers for the drug methotrexate. The researchers found that both nanostructures were able to release the drug inside cells and exhibited low toxicity. The chitosan-coated MNRs (C@MNRs) showed promise as an alternative to spherical nano-carriers for targeted drug delivery to specific cells. This study highlights the importance of considering the shape of nanoparticles in drug delivery research. [Extracted from the article]

A report from Isfahan University of Technology in Iran explores the role of mucociliary clearance in drug delivery systems. The study finds that while the airflow inside the main nasal cavity is not affected by mucociliary clearance, it does control the airflow inside the nasal sinuses. This leads to an increase in the residence time and absorption of drugs in the upper respiratory pathway. The research also investigates the effects of particle size and density on the absorption process. The findings suggest that drug delivery through the sinuses can reduce drug dosage and increase effectiveness. [Extracted from the article]

Researchers at the University of Isfahan in Iran have developed superparamagnetic iron oxide nanoparticle-loaded nanodroplets (NDs) for dual-modal ultrasound/magnetic resonance imaging (MRI)-guided drug delivery. The NDs contain folic acid (FA) as a targeting agent, methotrexate (MTX) as a chemotherapy drug, and superparamagnetic iron oxide nanoparticles (SPIONs) as an acoustic droplet vaporization (ADV) promoter and MRI contrast agent. The NDs were found to generate highly echogenic microbubbles and act as a T2-weighted MRI contrast agent. The study concluded that the SPIONs/MTX-FA NDs have potential as theranostic agents for dual-modal ultrasound/MRI-guided and acoustically-activated drug delivery. [Extracted from the article]

Researchers at the Pasteur Institute of Iran have developed a nanosized drug delivery system that can enhance the accumulation of therapeutic agents in tumors. The system involves the use of smaller nanoparticles loaded inside larger nanoparticles, which are released within the microvascular network through focused ultrasound. This results in a decrease in the size of the drug delivery system, allowing for higher penetration depths and sustained release of the drug. The researchers also developed a mathematical model to predict the performance of drug delivery systems. The proposed system shows promise for clinical applications and the mathematical model can be applied to broader applications. [Extracted from the article]

A recent study conducted by researchers at Shahid Sadoughi University of Medical Sciences in Iran explores the use of nanotechnology-based drug delivery systems in the treatment of melanoma. Melanoma is a type of skin cancer that is increasing in incidence globally. The study reviews various nanocarriers such as liposomes, niosomes, and transferosomes, and their potential advantages over conventional therapies for melanoma treatment. These nanocarriers have shown promise in inhibiting the spread of melanoma cells and reducing cell viability. The research provides valuable insights into the potential of nanotechnology in improving melanoma treatment. [Extracted from the article]

A research report from Islamic Azad University in Marvdasht, Iran, discusses the importance of ensuring proper medication dissolution when developing new solid dosage forms. The report explores the use of mathematical formulas to simplify quantitative analyses of dissolution outcomes. Various model equations, such as zero- and first-order, Hixson-Crowell, Weibull, and Korsmeyer-Peppas, were used to match experimental data and determine the best-fitting model. The research also examines different types of drug release mechanisms and introduces popular drug release modeling profiles. This peer-reviewed study provides valuable insights into drug delivery systems and their mathematical modeling. [Extracted from the article]

Keywords: Babolsar; Iran; Antiarrhythmic Agents; Antiasthmatic Agents; Drug Delivery; Drug Delivery Systems; Drugs and Therapies; Health and Medicine; Leukotriene Modifiers; Montelukast Therapy; Pharmaceuticals; Respiratory Agents EN Babolsar Iran Antiarrhythmic Agents Antiasthmatic Agents Drug Delivery Drug Delivery Systems Drugs and Therapies Health and Medicine Leukotriene Modifiers Montelukast Therapy Pharmaceuticals Respiratory Agents 2212 2212 1 11/06/23 20231110 NES 231110 2023 NOV 10 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Researchers detail new data in Drugs and Therapies - Drug Delivery Systems. Babolsar, Iran, Antiarrhythmic Agents, Antiasthmatic Agents, Drug Delivery, Drug Delivery Systems, Drugs and Therapies, Health and Medicine, Leukotriene Modifiers, Montelukast Therapy, Pharmaceuticals, Respiratory Agents Keywords for this news article include: Babolsar, Iran, Antiarrhythmic Agents, Antiasthmatic Agents, Drug Delivery, Drug Delivery Systems, Drugs and Therapies, Health and Medicine, Leukotriene Modifiers, Montelukast Therapy, Pharmaceuticals, Respiratory Agents, University of Mazandaran. [Extracted from the article]

Babolsar, Iran, Anticancer Agents, Antimetabolites, Antineoplastics, Breast Cancer, Cancer, Cancer Therapy, Drug Delivery, Drug Delivery Systems, Drugs and Therapies, Emerging Technologies, Fluorouracil Therapy, Health and Medicine, Nanotechnology, Oncology, Pharmaceuticals, Physics, Protective Agents, Quantum Dots, Quantum Physics, Women's Health Keywords: Babolsar; Iran; Anticancer Agents; Antimetabolites; Antineoplastics; Breast Cancer; Cancer; Cancer Therapy; Drug Delivery; Drug Delivery Systems; Drugs and Therapies; Emerging Technologies; Fluorouracil Therapy; Health and Medicine; Nanotechnology; Oncology; Pharmaceuticals; Physics; Protective Agents; Quantum Dots; Quantum Physics; Women's Health EN Babolsar Iran Anticancer Agents Antimetabolites Antineoplastics Breast Cancer Cancer Cancer Therapy Drug Delivery Drug Delivery Systems Drugs and Therapies Emerging Technologies Fluorouracil Therapy Health and Medicine Nanotechnology Oncology Pharmaceuticals Physics Protective Agents Quantum Dots Quantum Physics Women's Health 738 738 1 10/03/23 20231006 NES 231006 2023 OCT 3 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Fresh data on Oncology - Breast Cancer are presented in a new report. [Extracted from the article]

Iran, Breast Cancer, Cancer, Drug Delivery, Drug Delivery Systems, Drugs and Therapies, Emerging Technologies, Health and Medicine, Nanocomposites, Nanotechnology, Oncology, Women's Health, Esfahan Keywords: Esfahan; Iran; Breast Cancer; Cancer; Drug Delivery; Drug Delivery Systems; Drugs and Therapies; Emerging Technologies; Health and Medicine; Nanocomposites; Nanotechnology; Oncology; Women's Health EN Esfahan Iran Breast Cancer Cancer Drug Delivery Drug Delivery Systems Drugs and Therapies Emerging Technologies Health and Medicine Nanocomposites Nanotechnology Oncology Women's Health 137 137 1 09/19/23 20230922 NES 230922 2023 SEP 19 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New research on Oncology - Breast Cancer is the subject of a report. [Extracted from the article]

Keywords: Shahrood; Iran; Drug Delivery; Drug Delivery Systems; Drugs and Therapies; Emerging Technologies; Nanohybrids; Nanosheets; Nanotechnology; Physics; Quantum Dots; Quantum Physics EN Shahrood Iran Drug Delivery Drug Delivery Systems Drugs and Therapies Emerging Technologies Nanohybrids Nanosheets Nanotechnology Physics Quantum Dots Quantum Physics 2274 2274 1 08/28/23 20230901 NES 230901 2023 SEP 1 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Current study results on Nanotechnology - Nanosheets have been published. Shahrood, Iran, Drug Delivery, Drug Delivery Systems, Drugs and Therapies, Emerging Technologies, Nanohybrids, Nanosheets, Nanotechnology, Physics, Quantum Dots, Quantum Physics Keywords for this news article include: Shahrood, Iran, Drug Delivery, Drug Delivery Systems, Drugs and Therapies, Emerging Technologies, Nanohybrids, Nanosheets, Nanotechnology, Physics, Quantum Dots, Quantum Physics, Shahrood University of Technology. [Extracted from the article]

Moreover, obtained data reveals that TMZ encapsulation inside BNNT as well as appropriate capacity of nanotube for drug act like barrier against TMZ hydrolysis inside BNNT. Keywords: Shahrood; Iran; Cancer; Drug Delivery; Drug Delivery Systems; Drugs and Therapies; Emerging Technologies; Glioblastomas; Health and Medicine; Molecular Dynamics; Nanotechnology; Nanotubes; Oncology; Physics EN Shahrood Iran Cancer Drug Delivery Drug Delivery Systems Drugs and Therapies Emerging Technologies Glioblastomas Health and Medicine Molecular Dynamics Nanotechnology Nanotubes Oncology Physics 1209 1209 1 06/05/23 20230609 NES 230609 2023 JUN 5 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Researchers detail new data in Oncology - Glioblastomas. Keywords for this news article include: Shahrood, Iran, Cancer, Drug Delivery, Drug Delivery Systems, Drugs and Therapies, Emerging Technologies, Glioblastomas, Health and Medicine, Molecular Dynamics, Nanotechnology, Nanotubes, Oncology, Physics, Shahrood University of Technology. [Extracted from the article]

Keywords: Shahrood; Iran; Drug Delivery; Drug Delivery Systems; Drugs and Therapies; Emerging Technologies; Nanocomposites; Nanoparticles; Nanotechnology EN Shahrood Iran Drug Delivery Drug Delivery Systems Drugs and Therapies Emerging Technologies Nanocomposites Nanoparticles Nanotechnology 556 556 1 06/05/23 20230609 NES 230609 2023 JUN 9 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Researchers detail new data in Nanotechnology - Nanoparticles. Keywords for this news article include: Shahrood, Iran, Drug Delivery, Drug Delivery Systems, Drugs and Therapies, Emerging Technologies, Nanocomposites, Nanoparticles, Nanotechnology, Shahrood University of Technology. [Extracted from the article]

Keywords: Tehran; Iran; Antiparkinson Agents; Cabergoline; Cabergoline Therapy; Cancer; Central Nervous System Agents; Dopaminergic Antiparkinsonism Agents; Drug Delivery; Drug Delivery Systems; Drugs and Therapies; Emerging Technologies; Genetics; Health and Medicine; Hormones; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Nanodrugs; Nanofluids; Nanopharmaceuticals; Nanotechnology; Oncology; Pharmaceuticals; Prolactin Inhibitors EN Tehran Iran Antiparkinson Agents Cabergoline Cabergoline Therapy Cancer Central Nervous System Agents Dopaminergic Antiparkinsonism Agents Drug Delivery Drug Delivery Systems Drugs and Therapies Emerging Technologies Genetics Health and Medicine Hormones Lung Cancer Lung Diseases and Conditions Lung Neoplasms Nanodrugs Nanofluids Nanopharmaceuticals Nanotechnology Oncology Pharmaceuticals Prolactin Inhibitors 301 301 1 05/15/23 20230519 NES 230519 2023 MAY 16 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Fresh data on Oncology - Lung Cancer are presented in a new report. The news correspondents obtained a quote from the research from Pasteur Institute Iran, "Cabergoline (CAB) is a specific dopamine receptor (DR) agonist that suppresses tumor cell proliferation and induces cell death. [Extracted from the article]

Keywords: Zabol; Iran; Drug Delivery; Drug Delivery Systems; Drugs and Therapies; Emerging Technologies; Nanosystems; Nanotechnology EN Zabol Iran Drug Delivery Drug Delivery Systems Drugs and Therapies Emerging Technologies Nanosystems Nanotechnology 531 531 1 05/15/23 20230516 NES 230516 2023 MAY 16 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Research findings on Nanotechnology - Nanosystems are discussed in a new report. Iran, Drug Delivery, Drug Delivery Systems, Drugs and Therapies, Emerging Technologies, Nanosystems, Nanotechnology, Zabol This makes PAA a suitable polymer for drug delivery systems, especially oral drug delivery which deals with diverse pH environments in gastrointestinal tract. [Extracted from the article]

Iran, Anticancer Agents, Antineoplastics, BCR-ABL Tyrosine Kinase Inhibitors, Cancer, Cancer Therapy, Drug Delivery, Drug Delivery Systems, Drugs and Therapies, Emerging Technologies, Health and Medicine, Imatinib Therapy, Magnetic Nanoparticles, Varamin, Nanoadsorbent, Nanocarriers, Nanoparticles, Nanotechnology, Oncology, Pharmaceuticals, Protective Agents, Protein Kinase Inhibitors, Tyrosine Kinase Inhibitors Keywords for this news article include: Varamin, Iran, Anticancer Agents, Antineoplastics, BCR-ABL Tyrosine Kinase Inhibitors, Cancer, Cancer Therapy, Drug Delivery, Drug Delivery Systems, Drugs and Therapies, Emerging Technologies, Health and Medicine, Imatinib Therapy, Magnetic Nanoparticles, Nanoadsorbent, Nanocarriers, Nanoparticles, Nanotechnology, Oncology, Pharmaceuticals, Protective Agents, Protein Kinase Inhibitors, Tyrosine Kinase Inhibitors, Islamic Azad University. Keywords: Varamin; Iran; Anticancer Agents; Antineoplastics; BCR-ABL Tyrosine Kinase Inhibitors; Cancer; Cancer Therapy; Drug Delivery; Drug Delivery Systems; Drugs and Therapies; Emerging Technologies; Health and Medicine; Imatinib Therapy; Magnetic Nanoparticles; Nanoadsorbent; Nanocarriers; Nanoparticles; Nanotechnology; Oncology; Pharmaceuticals; Protective Agents; Protein Kinase Inhibitors; Tyrosine Kinase Inhibitors EN Varamin Iran Anticancer Agents Antineoplastics BCR-ABL Tyrosine Kinase Inhibitors Cancer Cancer Therapy Drug Delivery Drug Delivery Systems Drugs and Therapies Emerging Technologies Health and Medicine Imatinib Therapy Magnetic Nanoparticles Nanoadsorbent Nanocarriers Nanoparticles Nanotechnology Oncology Pharmaceuticals Protective Agents Protein Kinase Inhibitors Tyrosine Kinase Inhibitors 985 985 1 05/08/23 20230512 NES 230512 2023 MAY 9 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators publish new report on Nanotechnology - Nanocarriers. [Extracted from the article]

Keywords for this news article include: Rasht, Iran, Antibiotics, Antiinfectives, Dermatological Agents, Drug Delivery, Drug Delivery Systems, Drugs and Therapies, Emerging Technologies, Erythromycin Therapy, Health and Medicine, Macrolide Derivatives, Macrolides, Nanohybrids, Nanotechnology, Ophthalmic Antiinfectives, Ophthalmic Preparations, Pharmaceuticals, Topical Acne Agents, University of Guilan. Iran, Antibiotics, Antiinfectives, Dermatological Agents, Drug Delivery, Drug Delivery Systems, Drugs and Therapies, Emerging Technologies, Erythromycin Therapy, Health and Medicine, Macrolide Derivatives, Macrolides, Nanohybrids, Nanotechnology, Ophthalmic Antiinfectives, Ophthalmic Preparations, Pharmaceuticals, Topical Acne Agents, Rasht Keywords: Rasht; Iran; Antibiotics; Antiinfectives; Dermatological Agents; Drug Delivery; Drug Delivery Systems; Drugs and Therapies; Emerging Technologies; Erythromycin Therapy; Health and Medicine; Macrolide Derivatives; Macrolides; Nanohybrids; Nanotechnology; Ophthalmic Antiinfectives; Ophthalmic Preparations; Pharmaceuticals; Topical Acne Agents EN Rasht Iran Antibiotics Antiinfectives Dermatological Agents Drug Delivery Drug Delivery Systems Drugs and Therapies Emerging Technologies Erythromycin Therapy Health and Medicine Macrolide Derivatives Macrolides Nanohybrids Nanotechnology Ophthalmic Antiinfectives Ophthalmic Preparations Pharmaceuticals Topical Acne Agents 1498 1498 1 04/17/23 20230421 NES 230421 2023 APR 21 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- New research on Nanotechnology - Nanohybrids is the subject of a report. [Extracted from the article]

Keywords for this news article include: Malayer, Iran, Anticancer Agents, Cancer, Cancer Therapy, Drug Delivery, Drug Delivery Systems, Drugs and Therapies, Health and Medicine, Oncology, Protective Agents, Malayer University. Iran, Anticancer Agents, Cancer, Cancer Therapy, Drug Delivery, Drug Delivery Systems, Drugs and Therapies, Health and Medicine, Oncology, Protective Agents, Malayer Keywords: Malayer; Iran; Anticancer Agents; Cancer; Cancer Therapy; Drug Delivery; Drug Delivery Systems; Drugs and Therapies; Health and Medicine; Oncology; Protective Agents EN Malayer Iran Anticancer Agents Cancer Cancer Therapy Drug Delivery Drug Delivery Systems Drugs and Therapies Health and Medicine Oncology Protective Agents 1204 1204 1 03/24/23 20230228 NES 230228 2023 FEB 28 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- A new study on Drugs and Therapies - Anticancer Agents is now available. [Extracted from the article]